| ★ | FDA Expansion of Linaclotide for Children 2-5 Years With Functional Constipation | | 63 | Estados Unidos | |
| 19 | What to know about the new weight loss pill approved by the FDA | | 47.5K | — | 82 |
| 16 | FDA May Ease Peptide Restrictions Despite Doctor Warnings #healthline #FDA #peptides#wellness | Healthline @healthlinemedia | 7.3K | Estados Unidos | 82 |
| 9 | Wait this does what for kids autism and ADHD? | Shalee Bayne | Wellness & Honest Motherhood @shaleebayneofficial | 3.9K | Estados Unidos | 83 |
| 4 | Magnesium for autism and ADHD | Shalee Bayne | Wellness & Honest Motherhood @shaleebayneofficial | 1.4K | Estados Unidos | 83 |
| 2 | Diabetes Dialogue: FDA Approves Afrezza Inhaled Insulin for Pediatric Patients | | 683 | Estados Unidos | 84 |
| 8 | Enlicitide Receives FDA Approval for Hypercholesterolemia Following CORALreef Trials | | 681 | Estados Unidos | 83 |
| 18 | Terapia SMART en Pediatría | | 655 | España | 82 |
| 5 | One Year of Brensocatib: How Bronchiectasis Care Has Changed | | 399 | Estados Unidos | 83 |
| 1 | Afrezza’s Pediatric Approval and Improving Adolescent Diabetes Care | | 160 | Estados Unidos | 85 |
| 3 | Primeros 1.000 días: Oportunidad para modular el desarrollo del eje "Microbiota-Intestino-Cerebro" | | 123 | España | 83 |
| 17 | How Does the FDA Approval of Risankizumab Impact Pediatric Psoriasis and PsA? With Amy Paller, MD | | 109 | Estados Unidos | 82 |
| 20 | Preparing Families for the Exa-cel Gene Therapy Journey, With Haydar Frangoul, MD, MS | | 109 | Estados Unidos | 82 |
| 14 | Uso de probióticos en el lactante: Conceptos clave y abordaje de trastornos digestivos | | 104 | España | 82 |
| 12 | Ruxolitinib, Tapinarof, Roflumilast: What's New for Pediatric AD | | 102 | Estados Unidos | 82 |
| 10 | Exa-Cel Approval Expands to Children as Young as 2 With Haydar Frangoul, MD | | 100 | Estados Unidos | 83 |
| 7 | Your Child Constipated? Try These Proven Methods | Marietta Omega Pediatrics @omegapediatrics1841 | 76 | Estados Unidos | 83 |
| 13 | Volixibat Improves Itch, Fatigue in PSC, Supporting “Patient-Centered” Care | | 59 | Estados Unidos | 82 |
| 11 | ADorable-1 Results: Key Findings in Pediatric Atopic Dermatitis | | 58 | Estados Unidos | 83 |
| 15 | Diabetes Dialogue: Teplizumab, Stelo, and Inhaled Insulin Afrezza for Pediatric Patients | | 53 | Estados Unidos | 82 |
| 6 | Ersodetug Shows Target Engagement but Misses Primary Endpoints in Phase 3 cHI Study | | 20 | Estados Unidos | 83 |